<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/95D652A9-4A01-4AF0-926F-D22FBCC9D54A"><gtr:id>95D652A9-4A01-4AF0-926F-D22FBCC9D54A</gtr:id><gtr:name>Bedfont Scientific Limited</gtr:name><gtr:address><gtr:line1>STATION YARD , STATION ROAD</gtr:line1><gtr:city>HARRIETSHAM</gtr:city><gtr:postCode>ME17 1JA</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/95D652A9-4A01-4AF0-926F-D22FBCC9D54A" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>95D652A9-4A01-4AF0-926F-D22FBCC9D54A</gtr:id><gtr:name>Bedfont Scientific Limited</gtr:name><gtr:address><gtr:line1>STATION YARD , STATION ROAD</gtr:line1><gtr:city>HARRIETSHAM</gtr:city><gtr:postCode>ME17 1JA</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>82800.0</gtr:offerGrant><gtr:projectCost>207000.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=730047"><gtr:id>363A8DE3-68A3-4B8C-A559-E07014BE047D</gtr:id><gtr:title>Ammonia Projects</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Legacy RDA Grant for R&amp;D</gtr:grantCategory><gtr:grantReference>730047</gtr:grantReference><gtr:abstractText>Ammonia given off on exhaled breath can be used as an indicator of Helicobacter Pylori (HPylori)
infection. H-Pylori is one of the most common bacterial pathogens in humans and is
now recognised as a worldwide problem. It causes chronic gastritis, peptic ulcer disease, and
lymphoproliferative disorders and is a major risk factor for gastric cancer1?
There are considerable differences in H-pylori prevalence between high and low income
countries and, concerning children, the prevalence ranges from less than 10% to more than
80%, respectively2 ? In fact, it has been remarked that H-Pylori infection is a better indicator of
deprivation than deprivation itself3 ? In the UK the prevalence is about 30-40% of the
population. There are pockets of higher prevalence associated with depravation2 ?
At the present time there are number of different tests that are available to test for the
presence of H-Pylori infection, although they do not provide instant results and can be invasive.
These tests are also expensive to perform and involve sending samples to a laboratory to be
tested which is time consuming and expensive.
The Bedfont monitor will be used nearside the patient and will provide instant results in a
economical monitor with a cheaper cost per test, than other tests currently available, making
this testing more accessible and possibly prevent the number of ulcers through earlier detection
of H-Pylori. This will in turn reduce the prevalence of ulcers and other gastrointestinal diseases,
mentioned above, and cut down on the number of invasive tests that are carried out in the
NHS.
In 1994 a systematic review of Helicobacter Pylori was undertaken by Professor R A Moore in
Oxford. This found that the use of H-Pylori testing as a triage before Endoscopy has been
proven to reduce the numbers of endoscopies performed by as much as 25%, and save
additional sums of about &amp;pound;10 million per year to the NHS4 ?</gtr:abstractText><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2009-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>82800</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">730047</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>